The leukocyte integrin ␣ M ␤ 2 is a highly promiscuous leukocyte receptor capable of binding a multitude of unrelated ligands. To understand the molecular basis for the broad ligand recognition of ␣ M ␤ 2 , the inter-integrin chimera was created. In the chimeric integrin, the ␤D-␣5 loop-␣5 helix segment comprised of residues 
The integrin ␣ M ␤ 2 (CD11b/CD18, Mac-1) is the major receptor expressed primarily on the surface of phagocytic leukocytes such as neutrophils and monocytes and mediates critical adhesive reactions during the inflammatory responses. Numerous studies have shown that ␣ M ␤ 2 contributes to all steps of neutrophil trafficking, i.e. firm adhesion of neutrophils to the surface of activated endothelial cells, subsequent transmigration of adherent cells through the endothelium, and migration of leukocytes through the extracellular matrix to the site of inflammation (1) . In addition, evaluation of neutrophil functions in ␣ M ␤ 2 -deficient mice provided direct evidence that ␣ M ␤ 2 also mediates phagocytosis of opsonized particles, homotypic aggregation, and adhesion-dependent respiratory burst and degranulation (2, 3) . Complexity of the ␣ M ␤ 2 functions arises from its ability to recognize numerous ligands. ␣ M ␤ 2 is the most promiscuous member of the integrin family of adhesion receptors. To date, more than 30 protein and non-protein molecules have been reported to bind ␣ M ␤ 2 . Ligands with characterized functions include intercellular adhesion molecules 1, 2, and 3 (4), complement C3 fragment iC3b (5) , fibrinogen (Fg) 1 (6) , and neutrophil inhibitory factor (NIF) (7) . ␣ M ␤ 2 interacts with several plasma proteins and vascular cell receptors, including high molecular weight kininogen (8) , factor X (9), complement factor H (10), GPIb (11) , uPAR (12) , and E-selectin (13) . In addition, ␣ M ␤ 2 binds many extracellular matrix proteins, such as fibronectin, laminin, collagens, vitronectin, thrombospondin, Cyr61, and connective tissue growth factor (14 -20) . ␣ M ␤ 2 has also been reported to serve as a receptor for many pathogens such as Candida albicans (21) , Leishmania gp63 (22) , and Bordetella pertussis (23) . Another distinction of ␣ M ␤ 2 is its ability to bind a variety of structurally diverse molecules with unrelated functions. The extravagant repertoire of ␣ M ␤ 2 ligands includes keyhole limpet hemocyanin (24) , elastase (25) , myeloperoxidase (26) , catalase (14) , transferrin (14) , casein (14) , soybean trypsin inhibitor (14) , bovine serum albumin (27) , and ovalbumin (14) . At the other extreme, ␣ M ␤ 2 is able to bind non-protein ligands, such as heparin (28) , ␤-glucan (29) , and non-coated plastic (27) . Broad binding specificity exhibited by ␣ M ␤ 2 is not shared by the related leukocyte integrin ␣ L ␤ 2 even though these two integrins share some overlapping functional properties. Nonetheless, ␣ L ␤ 2 binds only intercellular adhesion molecules (4) . The molecular basis for such a broad ␣ M ␤ 2 substrate recognition is not known. Likewise, the physiological significance of the degenerate recognition properties of ␣ M ␤ 2 and the mechanisms of their regulation are not understood. Binding of many ligands, including Fg (30), fibronectin, 2 iC3b (30), NIF (32) , intercellular adhesion molecule 1 (30) , intercellular adhesion molecule 2 (33), Cyr61 (20) , connective tissue growth factor (20) , C. albicans (34) , and heparin (28) , is mediated through the ␣ M I domain, a ϳ24-kDa subdomain located close to the NH 2 terminus of the ␣ M subunit. These data suggest that the ␣ M I domain may be primarily responsible for binding of various ligands and, thus, contain sequences and/or structural information that allows ␣ M ␤ 2 to exhibit promiscuity in ligand binding.
The molecular requirements for ␣ M ␤ 2 binding to several ligands, including NIF (35), iC3b (36, 37) , and Fg (38) , were characterized, and critical amino acid residues in the ␣ M I domain that contribute to binding were identified. Previous studies of ␣ M ␤ 2 -ligand interactions emphasized the differences in binding of various ligands to the ␣ M I domain. It was proposed that overlapping, but not identical, binding sites in the ␣ M I domain are involved in ligand binding (39) and that a mosaic of different residues is responsible for selective binding of distinct ligands (40) . It is noteworthy that mutations of residues in one particular region of the ␣ M I domain, the ␣ M (Lys 245 -Arg 261 ) sequence, which forms a loop ␤D-␣5 and an adjacent helix ␣5 in the crystal structure (41) , invariably resulted in the decreased binding of ligands tested (35, 36, 38, 40) , suggesting that this sequence may be a common recognition site. More recently, we have shown that mutations in this region impaired the binding of the recombinant ␣ M I domain to the Fg recognition peptide ␥-(383-395) (P2-C) (38 IN) . The D 100 (M r 100,000) fragment of Fg was prepared by digestion of Fg with plasmin as described (42) . Fibronectin was isolated from fresh human blood by gelatin-agarose affinity chromatography (43) . Ovalbumin and BSA were purchased from Sigma, and keyhole limpet hemocyanin was from Calbiochem-Novabiochem. Recombinant Cyr61, synthesized in a baculovirus system using Sf9 insect cells, was purified from serum-free conditioned media by chromatography on Sepharose S as described (44) . NIF was a gift from Corvas International (San Diego, CA). The P2-C peptide (TMKIIPFNRLTIG), corresponding to Fg sequence ␥-(383-395), was synthesized and purified as described (45) . The hybridoma cell lines producing mAbs 44a (anti-␣ M ) and IB4 (anti-␤ 2 ) were obtained from ATCC (Manassas, VA). The mAbs were purified from their conditioned media using protein A-agarose according to the manufacturer's protocol (Amersham Biosciences). mAb 2LPM19c was obtained from Dako Corp. mAb 1413 (clone R7.1), directed against the ␣ L subunit, and mAb 1965 (clone JB1A), directed against ␤ 1 integrins, were from Chemicon International (Temecula, CA). mAb 24 (46) , which recognizes the epitope within the I-like domain of the common ␤ 2 subunit (47) in ␣ M ␤ 2 and ␣ L ␤ 2 , was a generous gift from Dr. Nancy Hogg (Imperial Cancer Research Fund, UK).
Generation of the Integrin Subunit Constructs-The coding region for the ␣ M integrin subunit was excised from the pCIS2M-␣ M vector, which was provided by Dr. E. Plow (Cleveland Clinic). The full-length cDNAs of the ␣ L and ␤ 2 subunits were cloned from a human Jurkat T lymphoblastoid cell line cDNA library. The library was synthesized from total cellular RNA using SuperScriptII reverse transcriptase (Invitrogen) as described previously (48) . The full-length cDNAs of ␣ M and ␣ L were cloned into pcDNA3.1/Neo(Ϫ) vector, and full-length cDNA of the ␤ 2 was cloned into pcDNA3.1/Hygro(Ϫ) vector (Invitrogen).
Site-directed mutagenesis of the ␣ M subunit was performed using the QuikChange TM mutagenesis kit (Stratagene, San Diego, CA). The pcDNA3.1/Neo(Ϫ) construct containing DNA encoding the full-length ␣ M was modified by site-directed mutagenesis using two mutagenic primers containing the desired mutation as previously described (38 (38) . The entire chimeric I domain was inserted into the ␣ L -pcDNA3.1 construct using the inserted ClaI 595 and endogenous BglII 1071 sites. Fig. 1 shows the schematic representation of the generated I domains. The accuracy of DNA sequences for the entire ␣ M , ␣ L , ␤ 2 , and mutants was verified by sequencing.
Cells and Stable Transfection of Integrin Subunit Constructs-Human embryonic kidney 293 cells were obtained from the ATCC and maintained in DMEM/F-12 (BioWhittaker, Walkersville, MD) supplemented with 10% FBS, 2 mM glutamine, 15 mM HEPES, 0.1 mg/ml streptomycin, and 0.1 unit/ml penicillin. Cells were stably transfected with pcDNA3.1 plasmids with inserted ␤ 2 and wild-type or mutant ␣ using LipofectAMINE TM 2000 reagent (Invitrogen). After 48 h at 37°C in 5% CO 2 , cells were harvested and cultured in medium with 500 g/ml G418 (Invitrogen) and 250 g/ml hygromycin (Invitrogen). After 14 days, surviving cells were collected, sorted, and analyzed using flow cytometry and immunoprecipitation.
Flow Cytometry-FACS analyses were performed to assess the expression of receptors on the surface of the cells transfected with wildtype and mutant forms of the ␣ M ␤ 2 and ␣ L ␤ 2 integrins. The cells were incubated with anti-␣ M mAb 44a, anti-␤ 2 mAb IB4, anti-␣ L mAb 1413, and the conformation-dependent mAb 24 and analyzed in a FACS Scan ™ (BD Biosciences) as described (38) . Populations of cells expressing similar amounts of the receptors were selected by fluorescence-activated cell sorting using a BD Biosciences FACS Vantage instrument.
Immunoprecipitation-The cells (5 ϫ 10 6 ) were labeled with 100 g of Immunopure Sulfo-NHS-LC-Biotin (Pierce) in 200 l of phosphatebuffered saline for 30 min at 22°C. The cells were solubilized with a lysis buffer (20 mM Tris, pH 7.4, 150 mM NaCl, 1% Triton X-100, 1 mM CaCl 2 , 1 mM phenylmethylsulfonyl fluoride, 100 g/ml leupeptin, 10 mM benzamidine) for 30 min at 22°C. The lysates were incubated with 10 g of normal mouse IgG (Sigma) and 50 l of Zysorbin-G (Zymed Laboratories Inc., San-Francisco, CA) for 2 h at 4°C. After centrifugation, the supernatant was incubated with 10 g of mAb IB4 (anti-␤ 2 ) for 2 h at 4°C. The integrin-mAb complex was captured by incubating with 50 l of protein A-Sepharose (Amersham Biosciences) for 2 h at 4°C. The immunoprecipitated proteins were eluted with SDS-PAGE loading buffer and analyzed by Western blotting. The Immobilon-P membranes (Millipore) were incubated with streptavidin conjugated to horseradish peroxidase and developed using enhanced SuperSignal chemiluminescent substrate (Pierce).
Adhesion and Migration Assays-For adhesion assays, the 96-well tissue culture plates (Corning Costar, Cambridge, MA) were coated with different concentrations of the P2-C peptide, D 100 fragment, Fg, and other protein ligands for 3 h at 37°C or overnight at 4°C. Ovalbumin and BSA were denatured by heating at 70°C for 1 h before immobilization on the plates. The wells were post-coated with 0.5% polyvinyl alcohol for 1 h at 22°C. The cells expressing wild-type or mutant forms of integrin receptors were labeled with 10 M calcein AM (Molecular Probes, Eugene, OR), and assays were performed as described previously (49) .
Cell migration assays were performed under sterile conditions using uncoated Transwell inserts with a pore size of 8 M and 6.5 mm in diameter (Corning Costar). The lower chambers contained 600 l of Fg at 50 g/ml in DMEM/F-12 medium. Cells were resuspended at a concentration of 3 ϫ 10 6 /ml in DMEM/F-12. 100-l aliquots of cells were placed in the upper chamber and incubated at 37°C in 5% CO 2 for 8 h. To label cells, calcein AM was added to the lower chamber at 10 M final concentration 2 h before completion of the migration assay. Assays were stopped by removing cells from the upper surface of the polycarbonate membrane by wiping the surface twice with a cotton-tipped applicator. The cells migrating to the bottom of the filter were detected using a CytoFluorII fluorescence plate reader (Applied Biosystems, Farmington, MA). Fig. 1 ). In addition, the wild-type ␣ M ␤ 2 and ␣ L ␤ 2 integrins were expressed to serve as a "positive" cell line that binds Fg and a "negative" cell line that does not bind Fg, respectively. Stable transfectants were established, and cell populations expressing similar levels of ␣ M ␤ 2 , ␣ L ␤ 2 , and chimeric integrins were selected by cell sorting using anti-␣ Mspecific mAb 44a, anti-␤ 2 -specific mAb IB4, and anti-␣ L mAb 1413 (Fig. 2A) . Because ␣ M (Lys 245 -Arg 261 ) is a short segment and it was grafted into the homologous position of the structurally similar ␣ L I domain, it was unlikely that the structure of the chimeric I domain was perturbed. Nevertheless, to support this assertion experimentally, we assessed the binding of mAb 24 (46) , which recognizes a cation-dependent and ligand-competent conformation of the receptor and which was used in previous studies as a sensitive probe of correct folding of ␣ M ␤ 2 and ␣ L ␤ 2 in recombinant cells (35, 36) . FACS analyses demonstrated that the wild-type and chimeric receptors exhibited a similar capacity to bind mAb 24 ( Fig. 2A, lower panel) . Cell expression and heterodimer association of the integrins were also evaluated by immunoprecipitation of detergent-lysed surface-labeled cells (Fig. 2B) . Anti-␤ 2 mAb IB4 immunoprecipitated both the ␣ and ␤ subunits from cells co-transfected with ␤ 2 and the wild-type ␣ M , ␣ L , or chimeric ␣ subunit. Thus, these results indicated that different ␣ subunits were assembled with ␤ 2 on the cell surface and that the insertion of the ␣ M (Lys 245 -Arg 261 ) did not affect heterodimer formation. Chimeric L/M Integrin Specifically Binds Fg and Fg Derivatives-The cell line expressing L/M integrin was first tested for its ability to adhere to immobilized P2-C, Fg, and the D 100 fragment. As shown in Fig. 3A , cells expressing the chimeric integrin demonstrated a dose-dependent and saturable adhesion to P2-C with ϳ30% of added cells adherent at the plateau (maximal adhesion). Adhesion of the L/M-expressing cells was similar to that of the wild-type ␣ M ␤ 2 -transfected cells (ϳ35% maximal adhesion) and was significantly higher than that of the wild-type ␣ L ␤ 2 -expressing cells (ϳ10% maximal adhesion). To determine the effect of ␣ M (Lys 245 -Arg 261 ) grafting on ligand binding properties of the chimeric integrin further, we tested cell adhesion to Fg and the D 100 fragment. Adhesion of the L/M-expressing cells to both physiologic ligands was essentially identical to that of the wild-type ␣ M ␤ 2 -expressing cells (Fig. 3B shown for Fg). In particular, adhesion of the L/M-expressing cells to Fg had a concentration-dependent pattern typical for adhesion of wild-type ␣ M ␤ 2 -expressing cells (50) . In contrast, the ␣ L ␤ 2 -mediated adhesion to Fg and D 100 was low (2-4%), and adhesion of mock-transfected cells was negligible. Microscopic examination of adherent cells confirmed that many chimera-expressing cells adhered to P2-C. However, the morphology of the cells was somewhat different from that of the wildtype ␣ M ␤ 2 -expressing cells (Fig. 4) ; although the wild-type ␣ M ␤ 2 -expressing cells were well spread, the L/M-expressing cells were rounded.
RESULTS

Cell Surface Expression and Subunit Assembly of the Wild
The specificity of the interaction between L/M chimera and P2-C was verified using soluble P2-C and function-blocking mAbs directed against ␣ M and ␤ 2 subunits. Adhesion of cells bearing the chimeric integrin to P2-C was inhibited by more than 95% at 200 g/ml soluble P2-C, similar to that of the wild-type ␣ M ␤ 2 -expressing cells (Fig. 5) . Also, adhesion of both cell lines was inhibited by mAb IB4 against the common ␤ 2 The immunoprecipitates were analyze by Western blotting using streptavidin conjugated to horseradish peroxidase. The integrin subunits were detected using an enhanced chemiluminescent substrate and exposed to Kodak BioMax film.
subunit (Fig. 5) . In contrast, only the ␣ M ␤ 2 -mediated adhesion was efficiently inhibited by anti-␣ M mAbs 44a and 2LPM19c, whereas the L/M-expressing cells were not sensitive to these mAbs (Fig. 5, shown for mAb 2LPM19c) . This is consistent with the data that the epitopes for mAbs 44a and 2LPM19c were localized to the sequences in the ␣ M I domain other than ␣ M (Lys 245 -Arg 261 ) and that the inhibitory effect of these mAbs on ␣ M ␤ 2 -mediated adhesion was likely allosteric (37) .
In addition, we have tested the effect of NIF, a high affinity inhibitor of ␣ M ␤ 2 -mediated neutrophil functions (7) residues in the recombinant ␣ M I domain have been previously identified as critical for P2-C binding (38) . To determine whether these residues are the docking sites for Fg within the holoreceptor, point mutations were introduced into the ␣ M cDNA by site-directed mutagenesis. HEK 293 cells were stably transfected with mutant ␣ M together with the wild-type ␤ 2 . Cell surface expression and heterodimer formation were confirmed by FACS analyses and immunoprecipitation (Fig. 6, A  and B) . The interaction of mAb 24 with all three mutant cell lines was similar to that of wild-type ␣ M ␤ 2 cells, verifying that introduction of point mutations did not perturb receptor conformations (Fig. 6A, lower panel) . To assess the ligand binding properties of the generated mutants, mutant cell lines were sorted to select expressors with a density of receptors similar to that of the ␣ M ␤ 2 -expressing cells. As shown in Fig. 6C Chimeric Integrin Acquires the Ability to Support Cell Migration to Fg-Cell adhesion and migration are intimately linked processes since cell locomotion requires successive integrin-mediated cell attachment and detachment from the substratum. Previous studies demonstrate that ␣ M ␤ 2 in HEK 293 cells is able to support cell migration to Fg and its derivatives (49, 51) . In contrast, the ␣ L ␤ 2-expressing HEK 293 cells, which are not able to engage Fg, had no ability to migrate to Fg (51) . That the ␣ M I domain is sufficient to confer the migratory phenotype to cells was demonstrated in the experiments in which the ␣ L I domain in ␣ L ␤ 2 was replaced with the ␣ M I domain (51) . Because the insertion of the ␣ M (Lys 245 -Arg 261 ) segment was capable of imparting the Fg binding function to ␣ L ␤ 2 , we have examined the role of this sequence in Fg-induced migration using a Transwell system. As shown in Fig. 7 , cells expressing the chimeric integrin were able to migrate to Fg as efficiently as the wild-type ␣ M ␤ 2 -expressing cells, whereas migration of the wild-type ␣ L ␤ 2 -expressing cells was at the background level. Thus, the insertion of the short segment from the ␣ M I domain into ␣ L ␤ 2 was sufficient to induce the migratory response in the L/M-expressing cells. (2, 27) . We also tested two extracellular matrix proteins, fibronectin and Cyr61, which have been recently demonstrated to bind ␣ M ␤ 2 through the ␣ M I domain (20) . 2 The proteins thrombin and plasminogen have not been previously reported to interact with ␣ M ␤ 2 and were selected randomly to emphasize the propensity of ␣ M ␤ 2 to bind a multitude of unexpected ligands. In addition, naked plastic was tested because ␣ M ␤ 2 -mediated adhesion of neutrophils and monocytes to plastic surfaces is the hallmark of this integrin. Each ligand has been tested for its ability to support adhesion of the wild-type ␣ M ␤ 2 -, ␣ L ␤ 2 -, and L/M-expressing cells. In all cases, adhesion of each cell line was measured with increasing concentrations of immobilized proteins. Adhesion was found to be dose-dependent and reached a plateau with all ligands. The results of adhesion to eight protein ligands and to non-coated plastic are summarized in Fig. 8 . The data are expressed as a percentage of added cells. The wild-type ␣ M ␤ 2 supported efficient cell adhesion to all tested ligands, whereas the ␣ L ␤ 2 -expressing cells adhered poorly. The chimeric integrin supported adhesion to keyhole limpet hemocyanin, fibronectin, Fg, ovalbumin, and to plastic similar to or better than that of the wild-type ␣ M ␤ 2 . Although cell adhesion to ovalbumin was weak compared with other ligands, it was clear that the chimeric integrin had gained the ability to support adhesion. Of particular note, L/M cells exhibited strong adhesion to non-coated plastic, suggesting that the ␣ M (Lys 245 -Arg 261 )-inserted segment is responsible for this phenotype. With other ligands, including Cyr61, BSA, thrombin, and plasminogen, the extent of adhesion mediated by the L/M integrin was also significantly greater than adhesion mediated by the ␣ L ␤ 2 -expressing cells. Thus, these data support a model in which the ␣ M (Lys 245 -Arg 261 ) sequence is essential for supporting ␣ M ␤ 2 binding to diverse ligands. (38) . In the crystal structure, the ␣ M (Lys 245 -Arg 261 ) sequence forms a ␤D-␣5 loop and a contiguous ␣5 helix, both exposed on the surface of the ␣ M I domain (41), making it a possible candidate for ligand recognition. However, the role of this segment in binding of P2-C and Fg by the whole ␣ M ␤ 2 heterodimer remained unclear because of the uncertainty as to the positioning of the ␣ M I domain in the context of ␣ M ␤ 2 . In ␣ M ␤ 2 , the ␣ M I domain is inserted within the NH 2 -terminal domain of the ␣ M subunit, which is folded into the ␤-propeller structure containing seven repeats, and it is predicted to be interposed between the second and third repeats of the ␤-propeller (52) (and reviewed in Ref. 53) . Recently, the crystal structure of the extracellular portion of the integrin ␣ v ␤ 3 has been solved (54) . The structure revealed that the upper surface of the ␤-propeller forms a broad interface with the ␤I-like domain of the ␤ subunit and that a large surface area is buried in this interface. Because ␣ v ␤ 3 does not contain the additional "inserted" (I domain) typical for ␤ 2 integrins, no definite information about the whereabouts of the ␣ M I domain can be extracted. Nevertheless, the crystal structure of ␣ v ␤ 3 and other considerations (55) (Fig. 3, A and B) . However, the morphology of adherent cells expressing wildtype ␣ M ␤ 2 and chimeric integrins was somewhat different, with ␣ M ␤ 2 -expressing cells being well spread and flat, whereas the L/M cells remained round and rarely spread (Fig. 4) (56) demonstrated that ␣ M ␤ 2 , in which the ␣ M I domain was deleted, the "I-less integrin," lost its ability to support cell adhesion to Fg and BSA. The role of the ␣ L I domain in ␣ L ␤ 2 as the major ligand binding site was also shown (56, 57) . Previous data suggested that the ␤-integrin subunit may participate in ligand binding by providing additional binding sites. Specifically, the ␤I-like domain in the ␤ 2 subunit was implicated in ligand binding function since mutations in the ␤ 2 -(134 -138) region inhibited adhesion of the ␣ M ␤ 2 -expressing cells to iC3b (39, 58) , Fg (39) and P2-C. 3 However, recent data provide evidence that the ␤ 2 subunit I-like domain has a regulatory rather than a direct role in ligand binding (47) . Moreover, because ␣ M ␤ 2 and ␣ L ␤ 2 share the common ␤ 2 subunit, the newly acquired adhesion activity of the L/M chimera evidently should be attributed entirely to the chimeric ␣ L /␣ M (Lys 245 -Arg 261 )I domain. Inter-integrin chimeras have proved to be valuable tools for the identification of sites determining ligand specificity for several integrins (53) . Because of the ability of ␣ M ␤ 2 to bind a multiplicity of ligands, it is reasonable to suggest the existence of the site that determines ␣ M ␤ 2 promiscuity rather than its specificity. To begin to define a common molecular denominator on which ␣ M ␤ 2 promiscuity in ligand recognition is based, we examined the role of the ␣ M (Lys 245 -Arg 261 ) segment in the binding of several unrelated ␣ M ␤ 2 ligands. As shown in Fig. 8 , grafting ␣ M (Lys 245 -Arg 261 ) imparted to the chimeric receptor full adhesive activity with some ligands and was also dominant for adhesion to others. Thus, our results provide initial insights into the possible mechanism of ␣ M ␤ 2 binding promiscuity. We propose that the ␣ M (Lys 245 -Arg 261 ) sequence is an essential component of ␣ M ␤ 2 for this integrin receptor to interact with a wide spectrum of adhesive ligands. At present, the molecular mechanism for such a short sequence to impart ligand promiscuity to ␣ L ␤ 2 is not fully understood. One possibility is that grafting ␣ M (Lys 245 -Arg 261 ) into ␣ L ␤ 2 may impose a conformational change in the receptor complex, disrupting the narrow ligand binding specificity of ␣ L ␤ 2 . However, the ability of the L/M chimera to interact with the conformation-dependent mAb 24, which is a widely used reporter of the ligand-competent conformation of the I domain (46) , suggests that this possibility is unlikely. An alternative possibility is that this sequence forms a critical co-ordination site in the ligand binding domain of ␣ M ␤ 2 . Previous studies demonstrated (59) that the ␤D-␣5 loop undergoes the conformational change upon transition of the ␣ M I domain between inactive "closed" and active "open" conformations, which might provide further control of ligand binding.
To account for recognition of many molecules, it has been suggested that the ␣ M ␤ 2 ligand specificity arises from the variable surface on the ␣ M I domain, which contains many docking residues that selectively engage different ligands (40) . Given that ␣ M ␤ 2 can bind a vast selection of ligands, the variability of docking residues should be large. An alternative possibility is a model in which a consensus region in ␣ M ␤ 2 is involved in binding of diverse molecules, as has been shown for several recognition systems, including hormone receptor complexes and the binding site of human Ig-Fc (60) . Based on the ability of the chimeric receptor to bind different proteins, ␣ M (Lys 245 -Arg 261 ) by itself or as a part of a larger surface might constitute a consensus binding region. It is currently unclear what intrinsic physical properties of ␣ M (Lys 245 -Arg 261 ) endow it with the ability to bind a broad range of ligands that lack structural similarity. Further systematic mutational analyses and structural studies will be required to characterize the role of this region in binding to different ligands.
The systems in which molecular promiscuity in ligand binding plays important roles are well known. They include the interaction of chaperones with their substrates (61), binding of peptides to MHC class I and II molecules (62), hormone-receptor complexes (63) , and multiple binding capabilities of some mAbs (64) . Insights into the molecular principles regulating binding promiscuity that emerged from these systems will be useful in elucidating the mechanisms of ␣ M ␤ 2 -ligand recognition. Finally, it is possible that defining the principles that govern the interaction of ␣ M ␤ 2 with substrates will lead to a better understanding of the physiological role of this integrin.
